10.12
Induced Pluripotent Stem Cells
Induced pluripotent stem cells, iPSCs, are mature, differentiated cells, such as skin cells, that are reprogrammed in the laboratory to be similar to undifferentiated embryonic stem cells. That is, they divide and are pluripotent, able to produce any cell type in the body. For example, retinal cells that could be used to replace damaged retinal tissue.
To create iPSCs, mature cells, like skin fibroblasts, are taken from a patient and put into culture. Then, typically, genes for transcription factors, are delivered by viral vectors into the cell nuclei, where they are incorporated into the genome.
The transcription factors then turn on genes that are expressed by embryonic stem cells. Effectively, dedifferentiating them and bringing them to a pluripotent state.
The cells can now divide, and ideally, be directed to produce a specific cell type in culture. The new cells could then be transplanted back into the patient to treat damage or disease with minimal risk of rejection, because they originated from the patient's own cells.
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem cells (iPSCs).
iPSCs are potentially valuable in medicine, because a patient who needs a particular cell type—for instance, someone with a damaged retina due to macular degeneration—could receive a transplant of the required cells, generated from another cell type in their own body. This is called autologous transplantation, and it reduces the risk of transplant rejection that can occur when tissues are transplanted between individuals.
The Process
To create iPSCs, mature cells such as skin fibroblasts or blood cells from a person are grown in culture. Then, genes for multiple transcription factors are delivered into the cells using a viral vector, and the transcription factor proteins are expressed using the cell’s machinery. The transcription factors then turn on many other genes that are expressed by embryonic stem cells, returning the cells to an undifferentiated, proliferative, and pluripotent state.
It is still being studied whether iPSCs are truly equivalent to embryonic stem cells, but they appear to be similar and can produce cells from all three germ layers of the body. As with other types of stem cells, scientists are learning how to promote the differentiation of specific cell types from iPSCs efficiently, so that the needed cell types can be produced in adequate quantities.
Early Clinical Trials
The first clinical trial transplanted retinal cells derived from iPSCs into patients with age-related macular degeneration. Since then, several iPSC clinical trials have been approved for the treatment of Parkinson’s disease, heart disease, and spinal cord injury. Cells taken from patients and turned into iPSCs are also being used to study their diseases in the laboratory. In general, iPSCs provide another source of stem cells for scientific research.
Induced pluripotent stem cells, iPSCs, are mature, differentiated cells, such as skin cells, that are reprogrammed in the laboratory to be similar to undifferentiated embryonic stem cells. That is, they divide and are pluripotent, able to produce any cell type in the body. For example, retinal cells that could be used to replace damaged retinal tissue.
To create iPSCs, mature cells, like skin fibroblasts, are taken from a patient and put into culture. Then, typically, genes for transcription factors, are delivered by viral vectors into the cell nuclei, where they are incorporated into the genome.
The transcription factors then turn on genes that are expressed by embryonic stem cells. Effectively, dedifferentiating them and bringing them to a pluripotent state.
The cells can now divide, and ideally, be directed to produce a specific cell type in culture. The new cells could then be transplanted back into the patient to treat damage or disease with minimal risk of rejection, because they originated from the patient's own cells.
- Induced Pluripotent Cell - A cell reprogrammed to act as a stem cell.
- Stem Cell Dedifferentiation - The process by which a differentiated stem cell reverts back to a multipotent state.
- Differentiated Stem Cells - Cells that have developed to perform specialized functions.
- Undifferentiated Cells - Cells that have not yet acquired a specialized function.
- Pluripotent Cells - Cells capable of giving rise to several different cell types.
- Define Induced Pluripotent Cell - Explain their origin and function (e.g., induced pluripotent cell).
- Contrast Stem Cell Dedifferentiation vs Differentiation - Discuss key differences (e.g., process, end result).
- Explore Examples of Undifferentiated Cells - Describe their nature (e.g., stem cells, progenitor cells).
- Explain Process of Differentiation and Dedifferentiation - discuss the changes that take place in the cell.
- Apply in Context - Explain the importance and applications of induced pluripotent stem cells in medical research.
- What are induced pluripotent cells and how are they different from other stem cells?
- What is stem cell dedifferentiation, and why is it important in regenerative medicine?
- How does differentiation change the function and role of a stem cell?
From Chapter 10:
Now Playing
10.12 : Induced Pluripotent Stem Cells
Gene Expression
3.5K Views
10.1 : Cell Specific Gene Expression
Gene Expression
13.9K Views
10.2 : Regulation of Expression Occurs at Multiple Steps
Gene Expression
21.1K Views
10.3 : Cis-regulatory Sequences
Gene Expression
9.7K Views
10.4 : Cooperative Binding of Transcription Regulators
Gene Expression
6.2K Views
10.5 : Prokaryotic Transcriptional Activators and Repressors
Gene Expression
21.0K Views
10.6 : Operons
Gene Expression
16.1K Views
10.7 : The Eukaryotic Promoter Region
Gene Expression
16.7K Views
10.8 : Co-activators and Co-repressors
Gene Expression
7.3K Views
10.9 : Eukaryotic Transcription Activators
Gene Expression
11.0K Views
10.10 : Eukaryotic Transcription Inhibitors
Gene Expression
9.2K Views
10.11 : Combinatorial Gene Control
Gene Expression
8.8K Views
10.13 : Master Transcription Regulators
Gene Expression
6.5K Views
10.14 : Epigenetic Regulation
Gene Expression
24.9K Views
10.15 : Genomic Imprinting and Inheritance
Gene Expression
33.8K Views